Clinical Trial Update: Effects of Inclisiran Combined With Statins on the Morphology of Coronary Vulnerable Plaques [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of inclisiran in combination with statins on the morphology of coronary vulnerable plaques in patients with corona…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Inclisiran (inclisiran)
• Statins (class) (HMG-CoA reductase inhibitor)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Coronary Artery Disease | Phase 4 | Status: RECRUITING